Kelsie L. Thu
- Molecular Biology top 5%
- Cancer Research top 2%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Cell Biology top 5%
- Co-authors
- Wan L. LamEmily A. VucicLarissa A. PikorTak W. MakMark R. BrayCarmen Dominguez‐BrauerJacqueline M. MasonHeiko Blaser
- Topics
- Epigenetics and DNA Methylation (19 papers)Cancer Genomics and Diagnostics (15 papers)RNA modifications and cancer (14 papers)
- Partner nations
- CanadaUnited StatesJapan
In The Last Decade
Kelsie L. Thu
62 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 121
- Molecular Biology 2.1k
- Cancer Research 859
- Oncology 777
- Pulmonary and Respiratory Medicine 684
- Cell Biology 388
Countries citing papers authored by Kelsie L. Thu
This map shows the geographic impact of Kelsie L. Thu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelsie L. Thu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelsie L. Thu more than expected).
Fields of papers citing papers by Kelsie L. Thu
This network shows the impact of papers produced by Kelsie L. Thu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelsie L. Thu. The network helps show where Kelsie L. Thu may publish in the future.
Co-authorship network of co-authors of Kelsie L. Thu
This figure shows the co-authorship network connecting the top 25 collaborators of Kelsie L. Thu. A scholar is included among the top collaborators of Kelsie L. Thu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelsie L. Thu. Kelsie L. Thu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 7 | |
| 3 | 38 | |
| 4 | 26 | |
| 5 | 27 | |
| 6 | 10 | |
| 7 | 14 | |
| 8 | 2 | |
| 9 | 44 | |
| 10 | 7 | |
| 11 | 59 | |
| 12 | 39 | |
| 13 | 223 | |
| 14 | 74 | |
| 15 | 55 | |
| 16 | 19 | |
| 17 | 37 | |
| 18 | 53 | |
| 19 | 3 | |
| 20 | 28 |
About Kelsie L. Thu
Kelsie L. Thu is a scholar working on Cancer Research, Molecular Biology and Cell Biology, having authored 63 papers that have together received 2.9k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (19 papers), Cancer Genomics and Diagnostics (15 papers) and RNA modifications and cancer (14 papers). The work is most often cited by research in Cancer Research (859 citations), Molecular Biology (2.1k citations) and Oncology (777 citations). Kelsie L. Thu has collaborated with scholars based in Canada, United States and Japan. Frequent co-authors include Wan L. Lam, Emily A. Vucic, Larissa A. Pikor, Tak W. Mak, Mark R. Bray, Carmen Dominguez‐Brauer, Jacqueline M. Mason, Heiko Blaser, Adi F. Gazdar and Raj Chari. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.